ETIL

Serial Number 97761200
774

Registration Progress

Application Filed
Jan 19, 2023
Under Examination
Approved for Publication
Aug 13, 2024
Published for Opposition
Aug 13, 2024
Registered

Trademark Image

ETIL

Basic Information

Serial Number
97761200
Filing Date
January 19, 2023
Published for Opposition
August 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
774
Status Date
Dec 12, 2024
Application
Pending
Classes
005

Rights Holder

KSQ Therapeutics, Inc.

03
Address
4 Maguire Road
Lexington, MA 02421

Ownership History

KSQ Therapeutics, Inc.

Original Applicant
03
Lexington, MA

KSQ Therapeutics, Inc.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
CHRISTINA M. LICURSI, ESQ.

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

22 events
Date Code Type Description Documents
Dec 12, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Dec 12, 2024 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Sep 11, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Aug 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 13, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 25, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 18, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 18, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 18, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 23, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals comprised of engineered cells for the treatment of cancer, infectious diseases, and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, renal, pulmonary, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, inflammatory, and autoimmune related diseases and disorders

Classification

International Classes
005